Activation of NK cells by ADCC antibodies and HIV disease progression

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 2, 2011, Pages 127-131

  Chung, Amy W ^a   Navis, Marjon ^a   Isitman, Gamze ^a   Wren, Leia ^a   Silvers, Julie ^b   Amin, Janaki ^c   Kent, Stephen J ^a,b,d   Stratov, Ivan ^a,b,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

ADCC; CD4 T cells; HIV; NK Cells; viral load

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY RESPONSE; ARTICLE; BLOOD AUTOTRANSFUSION; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADULT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 80052965433     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822c62b9     Document Type: Article

References (18)

1. Fauci AS, Johnston MI, Dieffenbach CW, et al. HIV vaccine research: the way forward. Science. 2008;321:530-532.
2. McMichael AJ, Hanke T. HIV vaccines 1983-2003. Nat Med. 2003;9: 874-880. (Pubitemid 36889929)
3. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. 2002;415:335-339. (Pubitemid 34087556)
4. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209-2220.
5. Karnasuta C, Paris RM, Cox JH, et al. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine. 2005;23:2522-2529. (Pubitemid 40332524)
6. Chung AW, Rollman E, Center RJ, et al. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol. 2009;182: 1202-1210.
7. Chung A, Rollman E, Johansson S, et al. The utility of ADCC responses in HIV infection. Curr HIV Res. 2008;6:515-519.
8. Baum LL, Cassutt KJ, Knigge K, et al. HIV-1 gp120-specific antibodydependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol. 1996;157:2168-2173. (Pubitemid 126449697)
9. Rook AH, Lane HC, Folks T, et al. Sera from HTLV-III/LAVantibodypositive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol. 1987;138: 1064-1067. (Pubitemid 17017885)
10. Nag P, Kim J, Sapiega V, et al. Women with cervicovaginal antibodydependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis. 2004;190:1970-1978. (Pubitemid 39564703)
11. Ljunggren K, Chiodi F, Biberfeld G, et al. Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains. J Immunol. 1988;140:602-605.
12. Stratov I, Chung A, Kent SJ. Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. J Virol. 2008;82:5450-5459. (Pubitemid 351705252)
13. Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol. 2005;5:835-843. (Pubitemid 41581665)
14. Kottilil S, Chun TW, Moir S, et al. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J Infect Dis. 2003;187:1038-1045. (Pubitemid 36399345)
15. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:46-53. (Pubitemid 46067385)
16. Ferrari G, Pollara J, Kozink D, et al. A HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent ADCC activity and defines a common ADCC epitope in human HIV-1 serum. J Virol. 2011 [publish ahead of print May 4, 2011] doi: 10.1128/JVI.00171-11.
17. Chung AW, Isitman G, Navis M, et al. Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci USA. 2011;108:7505-7510.
18. Hessell AJ, Hangartner L, Hunter M, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007;449:101-104. (Pubitemid 47373775)